Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07407894 · ClinicalTrials.gov registry record · NA
iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults
A NA study of Healthy Aging and Anti Aging, sponsored by Synbiotic Health.
- Recruiting
- Registry status
- NA
- Development phase
- 80
- Enrollment target
- 1
- Study location
NCT07407894: Recruiting NA study of Healthy Aging and Anti Aging, sponsored by Synbiotic Health.
NCT07407894 is a NA study of Healthy Aging and Anti Aging that is actively recruiting participants, run by Synbiotic Health. The registered enrollment target is 80 participants, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07407894, a NA study of Healthy Aging and Anti Aging, is actively recruiting participants, sponsored by Synbiotic Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation of aging-related biological pathways through the gut microbiome may influence health-related outcomes.
Primary Outcome
Changes in gene expression of biomarkers associated with biological aging, assessed by quantitative polymerase chain reaction (qPCR), compared between placebo and study product groups over the study duration, including stratified analyses based on Bifidobacterium abundance.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Bifidobacterium adolescentis iVS-1
Study Locations (1)
Florida
- MusB Research LLC - New Port Richey
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2026-02 |
| Est. Completion | 2027-01 |
| Phase | NA |
What NCT07407894 shows while recruiting
NCT07407894 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 119-participant average among 40 other Healthy Aging trials with a reported enrollment target (33% lower).
The record links to 2 conditions, with Healthy Aging appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT07407894 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07407894 about?
NCT07407894 is a clinical study titled "iVS-1 Probiotic Intervention Targeting Biological Aging in Midlife Adults". This study is a randomized, double-blind, placebo-controlled clinical trial designed to evaluate the effects of Bifidobacterium adolescentis (iVS-1) supplementation on biological aging markers, metabolic health, and functional health outcomes in midlife adults. The study explores whether modulation ...
What is the current status of trial NCT07407894?
This trial is currently recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2026-02. Estimated completion is 2027-01.
What conditions does trial NCT07407894 study?
This clinical trial studies the following conditions: Healthy Aging, Anti Aging.
What interventions are being tested in trial NCT07407894?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Bifidobacterium adolescentis iVS-1 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07407894?
This trial is sponsored by Synbiotic Health, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07407894 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07407894's enrollment target sits among peer trials
80 18th of 40 higher than 22 of 40 other Healthy Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Executive Control in Cognitively Healthy Older Adults: the MUltitasking STrategy (MUST) Study
RECRUITING · NA
-
The Mitopure Challenge to Detect Levels of Urolithin A in Dried Blood Spots
RECRUITING · NA
-
Absorption and Tolerability of Injectable Administration of Niagen®+, as Compared to NAD+
RECRUITING · NA
-
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
RECRUITING · NA
-
Reactive Balance Training for Fall Prevention
RECRUITING · NA
-
Neuromodulation and Fatigue
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia